Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis

Summary Background Routine vaccination of infants against Streptococcus pneumoniae (pneumococcus) needs substantial investment by governments and charitable organisations. Policymakers need information about the projected health benefits, costs, and cost-